Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation
NCT00584922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2019-07-15
Summary
The purpose of this study is to prospectively follow the next 200 patients who undergo catheter ablation of atrial fibrillation for symptoms and signs of esophageal injury.
Conditions
Interventions
- PROCEDURE
-
Endoscopy in group I (all patients)
Post procedure endoscopy, omeprazole 40 mg BID, sucralfate 1 gm BID for 2-4 weeks.
Sponsors & Collaborators
-
University of Oklahoma
lead OTHER
Principal Investigators
-
Karen Beckman, MD · University of Oklahoma
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-05
- Primary Completion
- 2011-03-11
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
A New Approach for Catheter Ablation of Atrial Fibrillation
NCT05989321 ·Status: COMPLETED
-
Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY
NCT04659213 ·Status: COMPLETED ·Phase: NA
-
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT02208102 ·Status: COMPLETED
-
Long-Term Follow-Up of Patients Undergoing Catheter Ablation
NCT00584558 ·Status: COMPLETED
-
Atrial Fibrillation Ablation on Gastric Motility "The AF Gut Study"
NCT01396356 ·Status: COMPLETED
-
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
NCT06354777 ·Status: ACTIVE_NOT_RECRUITING
-
Esophageal Cooling for AF Ablation
NCT03691571 ·Status: COMPLETED ·Phase: NA
-
Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure
NCT02846922 ·Status: COMPLETED
-
The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT01148914 ·Status: COMPLETED
-
Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation
NCT02958839 ·Status: UNKNOWN
-
Effect of Left Atrial Appendage Velocity on Left Atrial Structure and Function After Radiofrequency Ablation Combined With Left Atrial Appendage Occlusion
NCT04693871 ·Status: COMPLETED
-
Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients: Efficacy at 3 Months
NCT00259623 ·Status: COMPLETED ·Phase: NA
-
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?
NCT02129842 ·Status: COMPLETED
-
OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
NCT02204566 ·Status: COMPLETED ·Phase: NA
-
Evaluating Active Esophageal Cooling During Cardiac Ablation Procedures
NCT04063761 ·Status: COMPLETED ·Phase: NA
-
Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab
NCT06719921 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Esophageal Deviation in Atrial Fibrillation Ablation
NCT03261973 ·Status: COMPLETED ·Phase: NA
-
Termination of Persistent Atrial Fibrillation by Catheter Ablation
NCT04958928 ·Status: UNKNOWN
-
EHR-Embedded Decision Support to Prevent Stroke in Patients With AF
NCT04099485 ·Status: COMPLETED ·Phase: NA
-
Safety Monitoring of Patients Having Pulmonary Vein Ablation
NCT00590668 ·Status: COMPLETED
-
Esophageal Cooling in Radiofrequency Cardiac Ablation
NCT03481023 ·Status: COMPLETED ·Phase: NA
-
Shape vs Substrate in AF
NCT05993104 ·Status: WITHDRAWN
-
Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation
NCT03246594 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope
NCT00844584 ·Status: UNKNOWN ·Phase: NA
-
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
NCT04922281 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA